| Literature DB >> 25433043 |
Birgitta Nordgren1, Cecilia Fridén2, Ingrid Demmelmaier2, Gunnar Bergström2, Ingrid E Lundberg2, Alyssa B Dufour3, Christina H Opava4.
Abstract
OBJECTIVES: The aims of this study were to document adherence to and changes in health-enhancing physical activity (HEPA) levels and self-reported and assessed functioning and to explore aspects of adherence and response during the first year of an outsourced 2-year HEPA programme in people with RA.Entities:
Keywords: clinical trial; exercise; health behaviour; muscular strength; physical fitness; self-efficacy social cognitive theory; trans-theoretical model
Mesh:
Year: 2014 PMID: 25433043 PMCID: PMC4481374 DOI: 10.1093/rheumatology/keu444
Source DB: PubMed Journal: Rheumatology (Oxford) ISSN: 1462-0324 Impact factor: 7.580
Baseline data and 1 year changes for disease-related and psychosocial variables, performance tests and anthropometric measures
| Baseline mean ( | Year 1 baseline β ( | ||||
|---|---|---|---|---|---|
| Health,a VAS (0–100) | 214 | 31 (20.8) | 183 | −3.56 (1.59) | |
| Pain, VAS (0–100) | 218 | 29 (22.2) | 178 | −3.54 (1.71) | |
| Fatigue, VAS (0–100) | 217 | 37 (25.7) | 182 | −2.29 (1.57) | 0.0987 |
| Quality of life, EQ-5D (0–100) | 217 | 69 (18.4) | 188 | 5.29 (1.29) | |
| Activity limitation, HAQ-DI (0–3) | 218 | 0.53 (0.50) | 187 | −0.20 (0.02) | |
| Exercise self-efficacy (6–60) | 205 | 36 (11.8) | 183 | −3.30 (0.96) | |
| Fear avoidance beliefs (0–24) | 218 | 6 (4.4) | 188 | −1.09 (0.33) | |
| Social support, family (0–65) | 198 | 22 (14.1) | 186 | 1.85 (0.97) | 0.0566 |
| Social support, friends (0–65) | 189 | 27 (14.6) | 173 | 2.29 (1.05) | |
| OE long-term health = 10, | 217 | 172 (79) | 186 | 147 (79) | 0.2975 |
| OE RA symptoms = 10, | 217 | 77 (35) | 186 | 79 (42) | 0.0997 |
| Estimated VO2max, l/min | 173 | 2.10 (0.55) | 137 | 0.20 (0.13) | 0.1189 |
| Estimated VO2max, ml/kg/min | 173 | 28.65 (8.57) | 136 | 1.30 (0.43) | |
| Timed standing, sec | 214 | 22.6 (8.7) | 181 | −3.88 (0.41) | |
| Grip strength maximum (right), | 220 | 219.35 (113.07) | 184 | 14.23 (3.66) | |
| Grip strength average (right), | 220 | 186.30 (104.81) | 184 | 13.74 (3.32) | |
| BMI, kg/m2 | 211 | 26.7 (4.9) | 178 | −0.19 (0.13) | 0.1563 |
| Waist circumference, cm | 218 | 91.8 (13.5) | 182 | −1.91 (0.36) | |
| Systolic blood pressure, mmHg | 219 | 134.1 (16.4) | 182 | 0.74 (1.08) | 0.4956 |
| Diastolic blood pressure, mmHg | 219 | 81.7 (9.7) | 182 | 0.16 (0.59) | 0.7911 |
Alpha level set at 0.05 (shown in bold text). aGeneral health perception. EQ-5D: EuroQol five-dimensions questionnaire; HAQ-DI: Stanford Health Assessment Questionnaire Disability Index; OE: outcome expectations; VO2max: maximal oxygen uptake.
Adherence at different levels to the three programme components in relation to 1 year changes in general health perception, self-efficacy and timed standing (0 = non-adherer, 1 = adherer)
| Healtha VAS (0–100) | Exercise self-efficacy (6–60) | Timed standing, s | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Intervention component | Δmean ( | Δmean ( | Δmean ( | |||||||
| Circuit training, 50% | 0 | 91 | −2 (24.8) | 0.4648 | 85 | −7 (13.0) | 89 | −3 (6.4) | 0.0626 | |
| 1 | 91 | −4 (19.1) | 88 | 1 (12.1) | 92 | −5 (4.4) | ||||
| Circuit training, 70% | 0 | 134 | −2 (23.7) | 0.2131 | 126 | −5 (13.2) | 132 | −4 (6.0) | 0.3742 | |
| 1 | 48 | −6 (16.9) | 47 | 3 (10.5) | 49 | −4 (3.9) | ||||
| Circuit training, 90% | 0 | 160 | −2 (23.3) | 0.0308 | 151 | −4 (13.0) | 158 | −3 (5.7) | 0.7080 | |
| 1 | 22 | −8 (8.2) | 22 | 4 (11.5) | 23 | −3 (4.0) | ||||
| Total HEPA, 50% | 0 | 76 | −4 (24.2) | 0.7018 | 69 | −6 (14.1) | 0.0168 | 76 | −4 (5.1) | 0.6164 |
| 1 | 106 | −2 (20.7) | 104 | −1 (121) | 105 | −4 (5.8) | ||||
| Total HEPA, 70% | 0 | 128 | −2 (23.7) | 0.4266 | 119 | −4 (14.2) | 0.2019 | 127 | −4 (6.0) | 0.8310 |
| 1 | 54 | −5 (18.1) | 54 | −2 (10.2) | 54 | −4 (4.1) | ||||
| Total HEPA, 90% | 0 | 167 | −2 (22.3) | 0.0775 | 159 | −3 (13.5) | 0.2832 | 167 | −4 (5.6) | 0.6334 |
| 1 | 15 | −13 (18.1) | 14 | −1 (8.1) | 14 | −4 (4.4) | ||||
| Group meetings, 50% | 0 | 83 | −5 (20.2) | 0.0663 | 81 | −6 (13.5) | 82 | −2 (6.6) | ||
| 1 | 99 | −2 (23.6) | 92 | −1 (12.3) | 99 | −5 (4.2) | ||||
| Group meetings, 70% | 0 | 124 | −5 (21.1) | 0.3058 | 118 | −5 (13.4) | 122 | −3 (6.1) | 0.0755 | |
| 1 | 58 | 1 (23.7) | 55 | 1 (11.5) | 59 | −5 (3.9) | ||||
| Group meetings, 90% | 0 | 170 | −3 (22.5) | 0.3058 | 162 | −4 (12.9) | 0.0125 | 168 | −4 (5.6) | 0.4886 |
| 1 | 12 | 3 (15.9) | 11 | 6 (13.76) | 13 | −5 (3.9) | ||||
Alpha level set at 0.01 (shown in bold text). aGeneral health perception. HEPA: health-enhancing physical activity; VAS: visual analogue scale.
One-year changes in general health perception in relation to each of the three programme components
| Circuit traininga | Total HEPAb | Support group meetingsc | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Response variable | Mean ( | Mean ( | Mean ( | |||||||
| ΔHealthd, 10% | 0 | 83 | 46 (32.9) | 83 | 195 (82.5) | 0.1198 | 83 | 10 (5.6) | 0.9770 | |
| 1 | 99 | 60 (36.5) | 99 | 214 (78.7) | 99 | 10 (6.5) | ||||
| ΔHealthd, 20% | 0 | 91 | 46 (32.4) | 91 | 196 (83.0) | 0.1216 | 91 | 10 (6.0) | 0.4201 | |
| 1 | 91 | 61 (37.0) | 91 | 215 (77.9) | 91 | 10 (6.5) | ||||
0: non-responders; 1: responders. aCircuit training sessions recommended: ≥104. bPossible total HEPA sessions, including both circuit training and daily physical activity = 365. cSupport group meetings = 20–22. dHealth: general health perception. P ≤ 0.05 in bold. HEPA: health-enhancing physical activity.
Baseline characteristics of responders (at the 10% level) and non-responders
| Responders ( | Non-responders ( | ||
|---|---|---|---|
| Age, mean ( | 58 (9.9) | 60 (8.4) | 0.2173 |
| Females, | 66 (83) | 82 (79) | 0.5357 |
| University education, | 36 (45) | 62 (60) | |
| Income above average, | 50 (63) | 79 (7) | |
| Children at home, | 16 (20) | 15 (14) | 0.3164 |
| Disease duration, mean ( | 12.25 (8.62) | 11.68 (9.36) | 0.6804 |
| Co-morbidities, | |||
| 0 | 40 (50) | 41 (39) | |
| 1 | 6 (8) | 22 (21) | |
| ≥2 | 34 (44) | 41 (39) | |
| Health,a mean ( | 31 (21.0) | 26 (19.9) | 0.1198 |
| Pain, mean ( | 28 (21.3) | 25 (22.0) | 0.4611 |
| Fatigue, mean ( | 38 (25.8) | 33 (25.7) | 0.2269 |
| Quality of life, mean ( | 70 (17.3) | 72 (16.9) | 0.4686 |
| Activity limitation, mean ( | 0.56 (0.5) | 0.44 (0.5) | 0.1023 |
| Fear avoidance beliefs, mean ( | 6 (3.3) | 6 (5.0) | 0.5221 |
| Exercise self-efficacy, mean ( | 35 (12.2) | 35 (12.1) | 0.9809 |
| Social support, family, mean ( | 25 (15.0) | 28 (14.9) | 0.2428 |
| Social support, friends, mean ( | 20.62 (13.46) | 24 (14.4) | 0.1813 |
| OE long-term health = 10, | 67 (84.8) | 80 (78.4) | 0.2759 |
| OE RA symptoms = 10, | 24 (30.4) | 38 (37.4) | 0.3337 |
| Current HEPA, | 39 (49) | 69 (67) | |
| Estimated VO2max, mean ( | 2.05 (0.57) | 2.17 (0.54) | 0.1751 |
| Estimated VO2max, mean ( | 27.31 (7.18) | 29.91 (9.35) | 0.0591 |
| Timed standing, mean ( | 23.3 (7.5) | 20.8 (7.6) | |
| Grip strength maximum, mean ( | 203.88 (112.24) | 234.62 (117.33) | 0.0743 |
| Grip strength mean, mean ( | 169.96 (102.51) | 202.74 (108.64) | |
| BMI, mean ( | 27.1 (5.2) | 26.6 (4.9) | 0.5685 |
| Waist circumference, mean ( | 92.5 (14.1) | 91.8 (13.8) | 0.7046 |
| Systolic blood pressure, mean ( | 129.3 (15.3) | 134.6 (15.9) | |
| Diastolic blood pressure, mean ( | 81.0 (9.1) | 81.02 (9.9) | 0.9611 |
Alpha levels set at 0.05 (shown in bold text). aGeneral health perception. EQ-5D: EuroQol five-dimensions questionnaire; HAQ-DI: Stanford Health Assessment Questionnaire Disability Index; HEPA: health-enhancing physical activity; OE: outcome expectations; VO2max: maximal oxygen uptake.